Last updated 24 days ago

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

153 patients around the world

Available in Argentina, Spain

Bristol-Myers Squibb

1Research sites

153Patients around the world

This study is for people with

Psoriasis

Plaque psoriasis

Requirements for the patient

To 18 Years

All Gender

Medical requirements

Sites

Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires

Recruiting

Bulnes 1937, CABA, Buenos Aireswww.psoriahue.com/

SponsorBristol-Myers Squibb

Study typeInterventional

Conditions

Plaque psoriasis

Requirements

To 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT04772079